Cargando…

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache

BACKGROUND: Medication Overuse Headache (MOH) is a prevalent and disabling disorder resulting from the overuse of analgesic drugs, triptans or other acute headache medications. In previous proteomic studies, several proteins have been found at high concentrations in the urine of MOH patients and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellesi, Lanfranco, Bellei, Elisa, Guerzoni, Simona, Cainazzo, Maria Michela, Baraldi, Carlo, Monari, Emanuela, Pini, Luigi Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798334/ https://www.ncbi.nlm.nih.gov/pubmed/31623575 http://dx.doi.org/10.1186/s12883-019-1469-1

Ejemplares similares

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2015)

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2013)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
por: Bellei, Elisa, et al.
Publicado: (2011)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment
por: Guerzoni, Simona, et al.
Publicado: (2016)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
por: Pellesi, Lanfranco, et al.
Publicado: (2017)

Clinical Evidence of Cannabinoids in Migraine: A Narrative Review
por: Lo Castro, Flavia, et al.
Publicado: (2022)

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

Urinary Proteomics in Biomarker Discovery of Kidney-Related Disorders: Diabetic Nephropathy and Drug-Induced Nephrotoxicity in Chronic Headache
por: Bellei, Elisa, et al.
Publicado: (2018)

A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants
por: Bacchelli, Elena, et al.
Publicado: (2016)

Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study
por: Stefani, Alessandro, et al.
Publicado: (2020)

Nabilone administration in refractory chronic diarrhea: a case series
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Serum protein changes in a rat model of chronic pain show a correlation between animal and humans
por: Bellei, Elisa, et al.
Publicado: (2017)

Predictors of response to erenumab after 12 months of treatment
por: Baraldi, Carlo, et al.
Publicado: (2021)

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study
por: Rustichelli, Cecilia, et al.
Publicado: (2020)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache
por: Cainazzo, Maria Michela, et al.
Publicado: (2015)

Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
por: Rustichelli, Cecilia, et al.
Publicado: (2021)

Proteomics Disclose the Potential of Gingival Crevicular Fluid (GCF) as a Source of Biomarkers for Severe Periodontitis
por: Bellei, Elisa, et al.
Publicado: (2022)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study
por: Cevoli, Sabina, et al.
Publicado: (2017)

A case of a GH–producing pituitary adenoma associated with a unilateral headache with autonomic signs
por: Marzocchi, N., et al.
Publicado: (2005)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rhm3mgrb2lbfig1ril8llglip9